Important Announcements

Nondiscrimination Statement Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To see our full nondiscrimination statement, click here.

Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

 

Boston Medical Center (BMC), a national leader in health equity, and premier academic medical center and principal teaching affiliate of Boston University Chobanian & Avedisian School of Medicine, affiliated physicians and surgeons from across 47 specialties were named in Boston Magazine’s 2024 Top Doctors guide. BMC’s award-winning physicians and surgeons design comprehensive care with and for patients and more than 125 BMC-affiliated physicians and surgeons were recognized as best in their fields.

BMC, ranked the most inclusive hospital in the U.S. by the Lown Institute, is actively shaping the future of medicine. BMC is pioneering advanced treatments, tackling complex medical conditions, developing integrated care models and expanding what is considered medicine to address the root cause of health inequities. BMC clinical teams are renowned in their fields of care and research and committed to interrogating disparities to advance innovative interventions to improve patients’ health. The Boston Magazine 2024 Top Doctors guide provides a view into the care being delivered across BMC’s expert and compassionate group of clinicians. 
 

Cardiac Electrophysiology

Cardiology

Gary J. Balady, MD

Director of Non-Invasive Cardiovascular Labs and Preventive Cardiology

Ashvin N. Pande, MD

Invasive Cardiology, Vascular Medicine

Director, Interventional Cardiology

Child Neurology

Clinical Genetics

Dermatology

Developmental-Behavioral Pediatrics

Diagnostic Radiology

Endocrinology, Diabetes & Metabolism

Facial Plastic Surgery/ Otolaryngology

Family Medicine

Gastroenterology

Geriatric Medicine

Hand Surgery

Hematology

Infectious Disease

Internal Medicine

Interventional Cardiology

Interventional Neuroradiology

Maternal & Fetal Medicine

Medical Oncology

Nephrology

Neurology

Neuroradiology

Neurosurgery

Obstetrics & Gynecology

Ophthalmology

Orthopedic Surgery

Otolaryngology

Pain Medicine

Pediatrics

Pediatric Cardiology

Pediatric Dermatology

Pediatric Infectious Disease

Pediatric Otolaryngology

Pediatric Pulmonology

Robyn T. Cohen, MD, MPH

Associate Medical Director of Asthma Initiatives, Population Health Services, Boston Medical Center Health System

Pediatric Rheumatology

Pediatric Surgery

Plastic Surgery

Psychiatry

Pulmonary Disease

Elizabeth S. Klings, MD

Pulmonologist, Director of the Center for Excellence in Sickle Cell Disease, Director of the Pulmonary Hypertension Center

Radiation Oncology

Reproductive Endocrinology/ Infertility

Rheumatology

Surgery

Donald T Hess, MD

Chief of Minimally Invasive and Weight Loss Surgery; Chief of General Surgery

Thoracic & Cardiac Surgery

Urology

Vascular Surgery

Methodology

The Boston Magazine 2024 Top Doctors guide is based on research conducted by Castle Connolly as a part of Castle Connolly’s Top Doctors 2024 list. Therefore, discrepancies may exist. The list was developed based on peer-nomination of board-certified U.S.-based physicians and Castle Connolly’s review of nominee’s qualifications, appointments, outcomes, and reputation, among other factors. 

More From Boston Magazine

With the recent FDA approval news, see how BMC's world-renowned Center of Excellence in Sickle Cell Disease is uniquely qualified to offer eligible patients the transformative, first-ever gene therapies for the debilitating illness.

Read more